PropertyValue
?:abstract
  • COVID-19 is a world health emergency which may inevitably affect the management of a complex autoimmune disease such as systemic sclerosis (SSc). Several SSc patients are frail and, in this pandemic, need a careful protection. The COVID-19 infection might complicate the clinical scenario of interstitial lung disease (ILD) in SSc because it determines a severe pneumonia characterized by radiological features similar to SSc-ILD. The striking CT similarities between the 2 diseases make it difficult to distinguish a worsening of SSc-ILD from COVID-19-ILD superinfection. Moreover, other aspects, like isolation during lock down, may cause a significant psychological stress which will pile up on the already difficult contact with the patients for a routine check-up. Moreover, the drug shortage is a real problem in these times. For these reasons, the rheumatologist in daily clinical practice should carefully differentiate the possible COVID-19 infection in order to optimize the patient management. Therefore, the challenge in everyday life will be to achieve in due time the differential diagnosis as well as the long-term psychological impact.
?:creator
?:doi
  • 10.1007/s10067-020-05193-2
?:doi
?:journal
  • Clin_Rheumatol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/3e8bad7180a29902a5defbdf80ee9811ef8bb10e.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7276334.xml.json
?:pmcid
?:pmid
?:pmid
  • 32514674.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress
?:type
?:year
  • 2020-06-08

Metadata

Anon_0  
expand all